6/18/2013

A draft bill being circulated for comment in the House does not define a "compounding pharmacy" or create a special category for drug compounders as a Senate bill does but instead clarifies how the FDA should tell drug compounders apart from drug manufacturers.

Full Story:
FDALawBlog.net

Related Summaries